<DOC>
	<DOCNO>NCT00327015</DOCNO>
	<brief_summary>The purpose trial understand add saxagliptin metformin therapy safe work well take either saxagliptin metformin alone</brief_summary>
	<brief_title>A Phase 3 Study BMS-477118 Combination With Metformin Subjects With Type 2 Diabetes Who Are Not Controlled With Diet Exercise</brief_title>
	<detailed_description>All subject participate lead-in period , qualify subject continue short-term randomized treatment period . Subjects complete short-term period eligible enter long term extension period . Also , subject short-term period elevate blood sugar require additional medication blood sugar control eligible enter long-term treatment extension period receive pioglitazone ( rescue medication ) add onto blind study medication</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes Inadequate blood sugar control No current treatment medication low blood sugar Major heart , liver kidney problem Pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>77 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>